Management

Hero Honda sales up 23.57% in January

The country"s largest two-wheeler maker Hero Honda today reported 23.57 per cent jump in its sales at 3,89,802 units in January compared to the same month"s last year. - M&M domestic auto sales jump 67.4%">M&M domestic auto sales jump 67.4% - Hero Honda keen on Karnataka - Firms In hurry to start work in U"Khand - Hero Honda net vrooms 78% - Hero Honda Q3 net soars 78% on strong sales - Hero Honda appoints Anand Burman as non-executive director Hero Honda is also planning to launch three new products by the end of this fiscal. In a statement, Hero Honda said it had sold 3,15,458 units in January last year. The figure registered during January is the highest-ever sales in the month by the company, it added. Besides, for the 13th consecutive time, the company has recorded more than three lakh despatches in a single month. "Our sales numbers for January provide an excellent start to the calendar year, 2010. The sales growth we have achieved is significant in light of the high base that we created in the same period last year," Hero Honda Motors Senior Vice President (Marketing & Sales) Anil Dua said. The company witnessed good performance in all the regions and sales across segments grew, he added. On its upcoming products, without giving any details, Dua said, "Going forward, we have three new product launches planned in the next two months, taking the total number of launches to nine this fiscal."


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Tata Sons' $1-bn infra fund to close by Dec
Tata Realty and Infrastructure, which hopes to develop projects worth Rs 20,000 crore over the next three years, today said that the $1 billion infrastructure fund, sponsored by its parent company Tata Sons, is expected to close by 2009-end.
Popular Articles
payday loans online

Revenue, transport secys in race for PFRDA top job
A four-member committee to shortlist the candidates.

Glenmark Pharma to repay Rs 300 cr debt by fiscal end
Pharma major Glenmark Pharmaceuticals is planning to repay its debt of around Rs 300 crore by end of this fiscal, a top company official said.